骨质疏松症治疗市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00004071
  • Category : Pharmaceuticals
  • Status : Data Released
  • No. of Pages : 150
Buy Now

市场概述

骨质疏松症是一种影响人类的疾病,其特点是骨密度和质量下降。此外,在这种情况下,骨头会变得多孔,使它们更加脆弱并且容易骨折。这种疾病是由过量的甲状旁腺激素引起的。这种情况可能会导致严重骨折,从而危害患者的健康。因此,这种情况需要治疗,其中包括服用骨质疏松症药物。市场上可用的一些治疗骨质疏松症的药物包括甲状旁腺激素治疗、降钙素、双膦酸盐选择性雌激素抑制剂调节剂 (SERM) 和 RANK 配体抑制剂。这些药物通过体内多种途径给药,例如口服途径和静脉途径。

市场范围

《到2028年全球骨质疏松症治疗市场分析》是对医疗保健行业的专业深入研究,特别关注全球市场趋势分析。该报告旨在概述骨质疏松症治疗市场,并按药物类型、给药途径和分销渠道进行详细的市场细分。该报告提供了领先的骨质疏松症治疗市场参与者的市场状况的关键统计数据,并提供了市场的主要趋势和机会。

市场细分

    • 根据药物类型,市场分为降钙素、双磷酸盐、选择性雌激素受体调节剂 (SERM)、Rank 配体 (RANKL) 抑制剂、甲状旁腺激素相关蛋白 (PTHrP) 类似物等。 • 根据给药途径,市场分为口服、注射和其他。 • 根据分销渠道,市场分为医院、零售药店和网上药店。

市场动态

驱动因素:

    • 全球骨质疏松症患病率不断上升。 • 全球老年人口不断增加,人们开始采用久坐的生活方式。 • 危险因素包括年龄较大、不健康的生活方式、吸烟、酗酒、合并症等。 • 提高对骨质疏松症治疗和疾病有效管理的认识。 • 存在用于治疗骨质疏松症的强大治疗药物管道。

限制:

    • 然而,长期治疗和耗时的产品审批程序带来的副作用预计将抑制市场增长。

区域框架

该报告提供了该行业的详细概述,包括定性和定量信息。它提供了基于各个细分市场的全球市场的概述和预测。它还提供了 2019 年至 2028 年五个主要地区的市场规模和预测估计,即:北美、欧洲、亚太地区 (APAC)、中东和非洲 (MEA) 以及南美洲。每个地区的骨质疏松症治疗市场随后按各自的国家和细分市场进行细分。该报告涵盖了全球18个国家以及该地区当前趋势和机遇的分析和预测。报告从需求和供给两个方面分析了影响市场的因素,并进一步评估了预测期内影响市场的市场动态,即驱动因素、限制因素、机会和未来趋势。该报告还为所有五个地区提供了详尽的 PEST 分析,即:在评估了北美、欧洲、亚太地区、中东和非洲和南美洲影响骨质疏松症治疗市场的政治、经济、社会和技术因素后。

COVID-19 对骨质疏松症治疗市场的影响

COVID-19 于 2019 年 12 月首次在中国武汉爆发,此后在全球范围内快速传播。从确诊病例和死亡人数来看,美国、印度、巴西、俄罗斯、法国、英国、土耳其、意大利和西班牙是受影响最严重的国家。由于封锁、旅行禁令和企业关闭,COVID-19 一直在影响各国的经济和行业。各种工厂和工厂的关闭影响了全球供应链,并对全球市场产品的制造、交货时间表和销售产生了负面影响。很少有公司已经宣布可能推迟产品交付以及未来产品销量的下滑。根据当前市场形势,报告进一步评估了COVID-19大流行对整体市场当前和未来的影响,给出了更可靠、更真实的预测。除此之外,欧洲、亚洲国家实施的全球旅行禁令——太平洋和北美正在影响业务合作和伙伴关系机会。

市场参与者

该报告涵盖了骨质疏松症治疗市场的主要发展,包括有机和无机增长策略。许多公司都专注于有机增长战略,例如产品发布、产品批准以及专利和活动等其他战略。市场上出现的无机增长战略活动包括收购、伙伴关系和合作。这些活动为市场参与者扩大业务和客户群铺平了道路。随着全球市场对骨质疏松症治疗需求的不断增长,骨质疏松症治疗市场的市场支付者预计未来将获得利润丰厚的增长机会。该报告还包括骨质疏松症治疗市场中主要公司的概况及其 SWOT 分析和市场策略。此外,该报告重点关注领先的行业参与者,提供公司简介、所提供的组件和服务、过去三年的财务信息、过去五年的关键发展等信息。 • 梯瓦制药工业有限公司 • 迈兰 NV • 雷迪博士实验室有限公司 • 武田制药有限公司 •  F. 霍夫曼-拉罗氏有限公司 •  Radius Health, Inc. • 葛兰素史克公司• 诺华公司 • 安进公司 • 旭化成制药公司 Insight Partner 的专门研究和分析团队由经验丰富的专业人士组成,具有先进的统计专业知识,并在现有研究中提供各种定制选项。
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which segment is dominating the osteoporosis treatment market?

The global osteoporosis treatment market, Based on drug class, the osteoporosis treatment market is segmented into RANKL, bisphosphonates, selective estrogen receptor modulators (SERM), hormone therapies, and others. The RANKL segment held the largest osteoporosis treatment market share in 2023. However, the hormone therapies segment is predicted to register the highest CAGR during 2021–2031. Based on type, is bifurcated into primary osteoporosis and secondary osteoporosis. The primary osteoporosis segment held a larger market share in 2023 and is estimated to record a faster CAGR during 2023–2031. Based on end user, the market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment held the largest osteoporosis treatment market share in 2023 and is estimated to register the highest CAGR during the forecasted period.

What was the estimated osteoporosis treatment market size in 2023?

The osteoporosis treatment market was valued at US$ 16.83 billion in 2023.

What are the growth estimates for the osteoporosis treatment market till 2031?

The osteoporosis treatment market is expected to be valued at US$ 22.72 billion in 2031.

Who are the major players in the osteoporosis treatment market?

The osteoporosis treatment market majorly consists of the players such as Pfizer Inc.; Amgen Inc.; Cadila Pharmaceuticals; Eli Lilly and Company; Daiichi Sankyo Company, Limited; Teva Pharmaceuticals Inc.; Asahi Kasei Corporation; Novartis AG; Chugai Pharmaceutical Co., Ltd.; and Teijin Pharma Limited.

What is osteoporosis treatment?

The osteoporosis treatment includes various drugs and therapeutic modalities carefully developed to combat osteoporosis, a disease characterized by bones becoming brittle and prone to fractures. As osteoporosis is a progressive disease, initiating the treatment at an early stage can yield better results. Osteoporosis treatment involves a series of bone density tests to determine the mineral proportion in the bones. Depending on the severity of cases, osteoporosis treatment is suggested to help reduce pain, improve mobility, and reduce the risk of disability.

What are the driving factors for the osteoporosis treatment market?

The factors driving the growth of the osteoporosis treatment market include the increasing cases of osteoporosis due to modifications in lifestyle and growing awareness and diagnosis of osteoporosis.

The List of Companies - Osteoporosis Treatment Market

  1. Pfizer Inc.
  2. Amgen Inc.
  3. Cadila Pharmaceuticals
  4. Eli Lilly and Company
  5. Daiichi Sankyo Company, Limited
  6. Teva Pharmaceuticals Inc.
  7. Asahi Kasei Corporation
  8. Novartis AG
  9. Chugai Pharmaceutical Co., Ltd.
  10. Teijin Pharma Limited

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports